ECCO2R-associated adverse effects
| Adverse effects (n) | ECCO2R group |
| Major bleeding | 7 |
| Scarpa’s fascia (cannula insertion site) | 3 |
| During cannula removal | 1 |
| Retroperitoneal haematoma (psoas) | 1 |
| Haemothorax | 1 |
| Pectoral bleeding | 2 |
| Cerebral bleeding | 0 |
| Digestive bleeding | 0 |
| ˃Two globular transfusions | 7 |
| Time to onset from cannulation (days) | 4±3,7 |
| Leading to premature discontinuation of ECCO2R | 3 |
| Minor bleeding | 6 |
| Scarpa’s fascia (cannula insertion site) | 3 |
| During cannula removal | 3 |
| Epistaxis | 1 |
| Haematuria | 2 |
| Device-related complications | 15 |
| Circuit thrombosis | 3 |
| Unexplained device discontinuation | 1 |
| Slow decrease in PaCO2 value | 2 |
| Haemolysis | 3 |
| Thrombocytopenia<100 G/L | 6 |
| Causes of premature discontinuation of ECCO2R | 9 |
| Major bleeding | 3 |
| Circuit thrombosis | 3 |
| Unexplained device discontinuation | 1 |
| Haemolysis | 1 |
| Death | 1 |
Values are presented as mean±SD or number of events.
ECCO2R, extracorporeal CO2 removal.